Illuminare Biotechnologies Inc — Form D
Illuminare Biotechnologies Inc of Brooklyn, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-18. The offering totals $2.5M, of which $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-18
- Form: D
- Accession: 0001701523-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.4M
- Remaining: $126K
- Minimum investment: $5K
- Investors: 44
- Date of first sale: 2017-08-14
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-293139
Issuer
- Name: Illuminare Biotechnologies Inc
- CIK: 0001701523
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 327 St Marks Avenue Unit 2604, Brooklyn, NY, 11238
- Phone: 6094971282
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Robert Graifman | Director | Miami Beach, FL |
| Shay Grinfeld | Director | Hoboken, NJ |
| Sue Yao | Director | New York, NY |
| Shay Grinfeld | Executive Officer | Hoboken, NJ |
| Eric Edidin | Related Person | Fort Lauderdale, FL |
| Walter Greenblatt | Executive Officer | Brooklyn, NY |
| Walter Greenblatt | Related Person | Brooklyn, NY |
| Robert Graifman | Related Person | Miami Beach, FL |
| Andrew Fradkin | Related Person | Ketchum, ID |
| Shay Grinfeld | Related Person | Hoboken, NJ |
| Oliver Curme | Related Person | Chestnut Hill, MA |
| Brian Longstreet | Related Person | Westfield, NJ |
| Ezra Angrist | Related Person | Cohoes, NY |
Other filings by this issuer (2)
More